AAAAAA
Results:
1-20
|
Results: 20
Authors:
Aparicio, T
Ducreux, M
Baudin, E
Sabourin, JC
De Baere, T
Mitry, E
Schlumberger, M
Rougier, P
Citation: T. Aparicio et al., Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours, EUR J CANC, 37(8), 2001, pp. 1014-1019
Authors:
Baudin, E
Bidart, JM
Bachelot, A
Ducreux, M
Elias, D
Ruffie, P
Schlumberger, M
Citation: E. Baudin et al., Impact of chromogranin A measurement in the work-up of neuroendocrine tumors, ANN ONCOL, 12, 2001, pp. S79-S82
Authors:
Boulle, N
Baudin, E
Gicquel, C
Logie, A
Bertherat, J
Penfornis, A
Bertagna, X
Luton, JP
Schlumberger, M
Le Bouc, Y
Citation: N. Boulle et al., Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors, EUR J ENDOC, 144(1), 2001, pp. 29-36
Authors:
Baudin, E
Degorce, F
Citation: E. Baudin et F. Degorce, Methodological aspects and clinical value of chromogranin A assessment, M S-MED SCI, 17(4), 2001, pp. 438-447
Authors:
Cailleux, AF
Baudin, E
Schlumberger, M
Citation: Af. Cailleux et al., Usefulness of the diagnostic total body scan in differentiated thyroid cancer - Authors' response, J CLIN END, 86(2), 2001, pp. 949-950
Authors:
Gicquel, C
Bertagna, X
Gaston, V
Coste, J
Louvel, A
Baudin, E
Bertherat, J
Chapuis, Y
Duclos, JM
Schlumberger, M
Plouin, PF
Luton, JP
Le Bouc, Y
Citation: C. Gicquel et al., Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors, CANCER RES, 61(18), 2001, pp. 6762-6767
Authors:
Baudin, E
Pellegriti, G
Bonnay, M
Penfornis, A
Laplanche, A
Vassal, G
Schlumberger, M
Citation: E. Baudin et al., Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p ' DDD)levels on the treatment of patients with adrenocortical carcinoma, CANCER, 92(6), 2001, pp. 1385-1392
Authors:
Guignat, L
Bidart, JM
Nocera, M
Comoy, E
Schlumberger, M
Baudin, E
Citation: L. Guignat et al., Chromogranin A and the alpha-subunit of glycoprotein hormones in medullarythyroid carcinoma and phaeochromocytoma, BR J CANC, 84(6), 2001, pp. 808-812
Authors:
Delord, JP
Raymond, E
Chaouche, M
Ruffie, P
Ducreux, M
Faivre, S
Boige, V
Le Chevalier, T
Rixe, O
Baudin, E
Pautier, P
Rodier, JM
Chouaki, N
Escudier, B
Kayitalire, L
Armand, JP
Citation: Jp. Delord et al., A dose-finding study of gemcitabine and vinorelbine in advanced previouslytreated malignancies, ANN ONCOL, 11(1), 2000, pp. 73-79
Authors:
Francey, AM
Ducreux, M
Fassone, F
Baudin, E
Sabourin, JC
Rougier, P
Citation: Am. Francey et al., Secondary appearance of hypoglycemia in a patient with a malignant neuroendocrine pancreatic tumor, GASTRO CL B, 24(2), 2000, pp. 234-235
Authors:
Cailleux, AF
Baudin, E
Travagli, JP
Ricard, M
Schlumberger, M
Citation: Af. Cailleux et al., Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?, J CLIN END, 85(1), 2000, pp. 175-178
Authors:
Logie, A
Boudou, P
Boccon-Gibod, L
Baudin, E
Vassal, G
Schlumberger, M
Le Bouc, Y
Gicquel, C
Citation: A. Logie et al., Establishment and characterization of a human adrenocortical carcinoma xenograft model, ENDOCRINOL, 141(9), 2000, pp. 3165-3171
Authors:
Nocera, M
Baudin, E
Pellegriti, G
Cailleux, AF
Mechelany-Corone, C
Schlumberger, M
Citation: M. Nocera et al., Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine, BR J CANC, 83(6), 2000, pp. 715-718
Authors:
Niccoli-Sire, P
Murat, A
Baudin, E
Henry, JF
Proye, C
Bigorgne, JC
Bstandig, B
Modigliani, E
Morange, S
Schlumberger, M
Conte-Devolx, B
Citation: P. Niccoli-sire et al., Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients, EUR J ENDOC, 141(5), 1999, pp. 468-474
Authors:
Ciofu, A
Baudin, E
Chanson, P
Cailleux, AF
Comoy, E
Sabourin, JC
Ducreux, M
Schaison, G
Schlumberger, M
Citation: A. Ciofu et al., Catecholamine production in patients with gastroenteropancreatic neuroendocrine tumors, EUR J ENDOC, 140(5), 1999, pp. 434-437
Authors:
Leboulleux, S
Baudin, E
Young, J
Caillou, B
Lazar, V
Pellegriti, G
Ducreux, M
Schaison, G
Schlumberger, M
Citation: S. Leboulleux et al., Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma, EUR J ENDOC, 140(3), 1999, pp. 187-191
Authors:
Aubert-Petit, G
Baudin, E
Cailleux, AF
Pellegriti, G
Elias, D
Travagli, JP
Giraud, S
Richard, S
Schlumberger, M
Citation: G. Aubert-petit et al., Neuroendocrine tumors and von Hipple-Lindau disease: three cases, PRESSE MED, 28(23), 1999, pp. 1231-1234
Authors:
Baudin, E
Bidart, JM
Rougier, P
Lazar, V
Ruffie, P
Ropers, J
Ducreux, M
Troalen, F
Sabourin, JC
Comoy, E
Lasser, P
DeBaere, T
Schlumberger, M
Citation: E. Baudin et al., Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors, J CLIN END, 84(1), 1999, pp. 69-75
Authors:
Mitry, E
Baudin, E
Ducreux, M
Sabourin, JC
Rufie, P
Aparicio, T
Lasser, P
Elias, D
Duvillard, P
Schlumberger, M
Rougier, P
Citation: E. Mitry et al., Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin, BR J CANC, 81(8), 1999, pp. 1351-1355
Authors:
Richard, S
Giraud, S
Beroud, C
Caron, J
Penfornis, F
Baudin, E
Niccoli-Sire, P
Murat, A
Schlumberger, M
Plouin, PF
Conte-Devolx, B
Citation: S. Richard et al., von Hippel-Lindau (VHL) disease: recent progress in genetics and patient management, ANN ENDOCR, 59(6), 1998, pp. 452-458
Risultati:
1-20
|